X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (21634) 21634
Book Review (5332) 5332
Publication (1264) 1264
Newsletter (834) 834
Newspaper Article (197) 197
Magazine Article (181) 181
Conference Proceeding (75) 75
Book Chapter (48) 48
Trade Publication Article (14) 14
Transcript (14) 14
Book / eBook (11) 11
Dissertation (7) 7
Reference (5) 5
Web Resource (4) 4
Data Set (2) 2
Paper (1) 1
Presentation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (18966) 18966
humans (18605) 18605
hypoglycemic agents - therapeutic use (11633) 11633
male (10106) 10106
female (9693) 9693
diabetes mellitus, type 2 - drug therapy (9537) 9537
hypoglycemic agents - adverse effects (8944) 8944
diabetes (7267) 7267
middle aged (6909) 6909
endocrinology & metabolism (6227) 6227
type 2 diabetes (6079) 6079
hypoglycemic agents - administration & dosage (5705) 5705
aged (5317) 5317
adult (4949) 4949
insulin (4876) 4876
hypoglycemic agents (4577) 4577
animals (3736) 3736
glucose (3727) 3727
treatment outcome (3571) 3571
blood glucose - metabolism (3557) 3557
risk factors (3381) 3381
hypoglycemic agents - pharmacology (3291) 3291
metformin (3272) 3272
pharmacology & pharmacy (3235) 3235
insulin - therapeutic use (3206) 3206
diabetes mellitus, type 2 - blood (3200) 3200
diabetes therapy (2873) 2873
care and treatment (2795) 2795
glycemic control (2674) 2674
blood glucose - drug effects (2667) 2667
diabetes mellitus (2656) 2656
drug therapy (2528) 2528
mellitus (2470) 2470
research (2459) 2459
insulin - administration & dosage (2413) 2413
metformin - therapeutic use (2331) 2331
abridged index medicus (2269) 2269
insulin - adverse effects (2269) 2269
medicine, general & internal (2234) 2234
hypoglycemia - chemically induced (2228) 2228
analysis (2164) 2164
hypoglycemia (2130) 2130
insulin resistance (2094) 2094
diabetes mellitus, type 2 - complications (2072) 2072
hyperglycemia (2059) 2059
diabetes mellitus - drug therapy (2021) 2021
drug therapy, combination (2006) 2006
glycated hemoglobin a - metabolism (1983) 1983
diabetes mellitus, type 1 - drug therapy (1977) 1977
therapy (1847) 1847
risk (1823) 1823
health aspects (1732) 1732
internal medicine (1714) 1714
dextrose (1687) 1687
double-blind method (1583) 1583
rats (1569) 1569
mortality (1562) 1562
blood glucose - analysis (1549) 1549
metformin - adverse effects (1515) 1515
clinical trials (1509) 1509
adolescent (1494) 1494
double-blind (1455) 1455
time factors (1380) 1380
medicine & public health (1371) 1371
glycated hemoglobin a - analysis (1362) 1362
obesity (1296) 1296
dosage and administration (1292) 1292
thiazolidinediones - therapeutic use (1248) 1248
blood sugar (1223) 1223
dose-response relationship, drug (1220) 1220
aged, 80 and over (1207) 1207
mice (1200) 1200
management (1197) 1197
retrospective studies (1195) 1195
type 2 diabetes mellitus (1194) 1194
thiazolidinediones (1192) 1192
insulin-resistance (1188) 1188
safety (1185) 1185
administration, oral (1177) 1177
diabetics (1175) 1175
hypoglycemic agents - pharmacokinetics (1160) 1160
diabetes mellitus, type 2 - metabolism (1127) 1127
complications and side effects (1125) 1125
thiazolidinediones - adverse effects (1122) 1122
young adult (1106) 1106
medical research (1059) 1059
drug administration schedule (1057) 1057
type-2 diabetes-mellitus (1054) 1054
insulin - blood (1047) 1047
efficacy (1040) 1040
randomized controlled trials as topic (1015) 1015
glucagon-like peptide-1 (1008) 1008
body mass index (993) 993
complications (984) 984
metformin - administration & dosage (966) 966
type 1 diabetes (964) 964
glycosylated hemoglobin (953) 953
rosiglitazone (941) 941
diabetes mellitus, type 2 - physiopathology (939) 939
insulin - analogs & derivatives (939) 939
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (21467) 21467
German (432) 432
French (240) 240
Spanish (146) 146
Japanese (141) 141
Italian (72) 72
Dutch (57) 57
Russian (53) 53
Czech (38) 38
Danish (38) 38
Swedish (35) 35
Hungarian (34) 34
Polish (34) 34
Chinese (32) 32
Norwegian (32) 32
Portuguese (18) 18
Finnish (8) 8
Hebrew (6) 6
Turkish (5) 5
Romanian (4) 4
Slovak (3) 3
Croatian (2) 2
Korean (2) 2
Icelandic (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


JAMA, ISSN 0098-7484, 07/2016, Volume 316, Issue 3, pp. 313 - 324
Journal Article
Diabetologia, ISSN 0012-186X, 12/2013, Volume 56, Issue 12, pp. 2582 - 2592
The aim of this work was to evaluate the efficacy and safety of canagliflozin vs placebo and sitagliptin in patients with type 2 diabetes who were being... 
Sodium glucose co-transporter 2 (SGLT2) inhibitor | Medicine & Public Health | Human Physiology | Canagliflozin | Metabolic Diseases | Internal Medicine | Sitagliptin | Metformin | Type 2 diabetes mellitus | GLIPIZIDE | ADD-ON | SULFONYLUREA | DAPAGLIFLOZIN | MELLITUS | INADEQUATE GLYCEMIC CONTROL | DIET | ENDOCRINOLOGY & METABOLISM | DOUBLE-BLIND | 52-WEEK | INHIBITOR | Blood Pressure | Triazoles - administration & dosage | Triazoles - adverse effects | Thiophenes - adverse effects | Glycated Hemoglobin A - metabolism | Humans | Middle Aged | Pyrazines - administration & dosage | Glycated Hemoglobin A - drug effects | Body Weight - drug effects | Lipids | Male | Thiophenes - administration & dosage | Metformin - adverse effects | Hypoglycemic Agents - administration & dosage | Aged, 80 and over | Female | Metformin - administration & dosage | Sitagliptin Phosphate | Drug Therapy, Combination | Glucosides - adverse effects | Fasting | Treatment Outcome | Blood Glucose - drug effects | Diabetes Mellitus, Type 2 - blood | Glucosides - administration & dosage | Adolescent | Pyrazines - adverse effects | Aged | Blood Glucose - metabolism | Diabetes Mellitus, Type 2 - drug therapy | Hypoglycemic Agents - adverse effects | Type 2 diabetes | Complications and side effects | Care and treatment | Body weight | Glucose | Comparative analysis | Dextrose | Index Medicus
Journal Article
Diabetes Care, ISSN 0149-5992, 2014, Volume 37, Issue 8, pp. 2159 - 2167
OBJECTIVE To compare the efficacy and safety of dulaglutide, a once-weekly GLP-1 receptor agonist, with placebo and exenatide in type 2 diabetic patients. The... 
GLYCEMIC CONTROL | GLUCAGON-LIKE PEPTIDE-1 | EXENDIN-4 | SITAGLIPTIN | ENDOCRINOLOGY & METABOLISM | ANALOG LIRAGLUTIDE | OPEN-LABEL | LY2189265 | TREATED PATIENTS | Recombinant Fusion Proteins - adverse effects | Glucagon-Like Peptides - administration & dosage | Humans | Middle Aged | Male | Immunoglobulin Fc Fragments - administration & dosage | Thiazolidinediones - administration & dosage | Metformin - adverse effects | Peptides - administration & dosage | Hypoglycemic Agents - administration & dosage | Venoms - administration & dosage | Female | Metformin - administration & dosage | Drug Therapy, Combination | Glucagon-Like Peptides - analogs & derivatives | Immunoglobulin Fc Fragments - adverse effects | Recombinant Fusion Proteins - administration & dosage | Drug Administration Schedule | Venoms - adverse effects | Hypoglycemia - drug therapy | Thiazolidinediones - adverse effects | Blood Glucose - drug effects | Glucagon-Like Peptides - adverse effects | Aged | Diabetes Mellitus, Type 2 - drug therapy | Hypoglycemic Agents - adverse effects | Peptides - adverse effects | Type 2 diabetes | Care and treatment | Safety and security measures | Dosage and administration | Metformin | Comparative analysis | Exenatide | Clinical trials | Hemoglobin | Diabetes | Product safety | Drug dosages | Placebo effect | Index Medicus
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 09/2017, Volume 377, Issue 13, pp. 1228 - 1239
This trial, which compared once-weekly exenatide plus usual care with usual care alone in patients with type 2 diabetes with or without previous cardiovascular... 
MEDICINE, GENERAL & INTERNAL | RISK | EVENT LOWERING EXSCEL | GLUCOSE CONTROL | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Male | Exenatide | Peptides - administration & dosage | Incidence | Cardiovascular Diseases - complications | Hypoglycemic Agents - administration & dosage | Injections, Subcutaneous | Cardiovascular Diseases - epidemiology | Cardiovascular Diseases - mortality | Venoms - administration & dosage | Female | Diabetes Mellitus, Type 2 - complications | Double-Blind Method | Drug Administration Schedule | Venoms - adverse effects | Kaplan-Meier Estimate | Diabetes Mellitus, Type 2 - blood | Least-Squares Analysis | Aged | Diabetes Mellitus, Type 2 - drug therapy | Hypoglycemic Agents - adverse effects | Peptides - adverse effects | Type 2 diabetes | Usage | Patient outcomes | Outcome and process assessment (Health Care) | Reports | Dosage and administration | Drug therapy | Observations | Myocardial infarction | Cerebral infarction | Diabetes mellitus | Pancreatitis | Amylin | Cardiovascular disease | Patients | Thyroid carcinoma | Studies | Side effects | Pancreatic carcinoma | Pancreatic cancer | Diabetes | Health risk assessment | Heart diseases | Endocrinology | Pharmaceuticals | Index Medicus | Abridged Index Medicus | Clinical Medicine | Medical and Health Sciences | Klinisk medicin | Medicin och hälsovetenskap
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 07/2016, Volume 375, Issue 4, pp. 323 - 334
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 07/2015, Volume 373, Issue 3, pp. 232 - 242
Journal Article